NFCR's Role
The National Foundation for Cancer Research has been a dedicated partner to the GBM AGILE initiative, since its conception and continues to be a valued member of the Global Coalition for Adaptive Research (GCAR), heavily engaged in the design, execution, and further expansion of GBM AGILE.
NFCR’s History of Support
- Founding member of the National Biomarker Development Alliance, GBM AGILE’s initial sponsor
- Original strategic partner to GCAR, GBM AGILE’s current sponsor
- Leading financier of GBM AGILE’s efforts to date
- Founder of multiple researchers whose work is pertinent to glioblastoma and whose input greatly benefits GBM AGILE
Complementary Stakeholders and Principals
Sujuan Ba, Ph.D., the NFCR President, is a member of the GCAR Board of Directors and a member of the GBM AGILE Knowledge Network’s executive committee
Michael Wang, Ph.D., the NFCR Chief Strategy Officer, is a member of the GBM AGILE Knowledge Network’s executive committee
Webster Cavenee, Ph.D., the chairman of NFCR’s Scientific Advisory Board, is one of the GBM AGILE concept’s three original visionaries, GCAR’s Chief Scientific Officer and a member of the GBM AGILE Knowledge Network’s executive committee
W.K. Alfred Yung, M.D., a former NFCR fellow, is one of the GBM AGILE concept’s three original visionaries, GCAR’s Executive Vice President for International Collaborations and a member of the GBM AGILE Knowledge Network’s executive committee
The National Foundation for Cancer Research is committed its funding of GBM AGILE. To help support this program, CLICK HERE.
